Prof. Dr. Ahmet Özdoğan
KANSER · 4 min read

Laryngeal (Voice Box) Cancer: Early Signs, Staging and Treatment

A comprehensive ENT oncology guide on early symptoms of laryngeal cancer (hoarseness, dysphagia), risk factors, stage-specific treatment options (laser microsurgery, radiotherapy, total laryngectomy), and voice rehabilitation.

Published: 2026-07-05 · Updated: 2026-07-05

Laryngeal (Voice Box) Cancer: Early Signs, Staging and Treatment
Short answer

What is the difference between laryngopharyngeal and laryngeal cancer?

Laryngeal cancer develops in the voice box (larynx) itself and most often begins in the glottic region (vocal cords). Laryngopharyngeal cancer affects both the larynx and the surrounding pharyngeal region. Glottic laryngeal cancer has a better prognosis because hoarseness presents early; supraglottic and hypopharyngeal cancers present later symptoms and are often diagnosed at a more advanced stage.

TL;DR
  • Glottic laryngeal cancer presents with early hoarseness, giving a 90–95% 5-year survival when caught at Stage I. In smokers, hoarseness lasting more than 3 weeks is an urgent indication for laryngoscopy.

Laryngeal Cancer: Epidemiology and Anatomy

Laryngeal cancer accounts for approximately 25% of all head and neck cancers and is 4–5 times more common in men than women. The most common age group is 50–70. Anatomically, the larynx is divided into three regions: glottic (vocal cords), supraglottic (epiglottis, aryepiglottic folds, false cords), and subglottic. 65% of tumours begin in the glottic region, 32% in the supraglottic. Glottic tumours present with early hoarseness and are therefore usually diagnosed early, resulting in dramatically better prognosis.

Early Symptoms and Warning Signs

Hoarseness is the earliest and most valuable symptom of glottic laryngeal cancer. Because diagnosis is usually made early, 5-year survival reaches 90–95%. In supraglottic cancer, voice change occurs late; early symptoms are dysphagia, foreign body sensation, ear-referred pain (otalgia), and a neck mass. Warning signs to highlight: hoarseness lasting more than 3 weeks, especially in smokers; pain on swallowing; stridor; a palpable neck mass; unexplained weight loss.

Diagnosis: Laryngoscopy and Staging

Laryngoscopy is the primary diagnostic tool when laryngeal cancer is suspected. Flexible fiberoptic laryngoscopy in the clinic, and rigid laryngoscopy under general anaesthesia for biopsy and histological diagnosis. Videostroboscopy evaluates vocal cord vibration and shows tumour invasion of the cord. Neck-thorax CT investigates regional lymph node involvement and distant metastasis. PET-CT is used in advanced disease. The AJCC TNM staging system is determinative in treatment decisions.

Stage-Based Treatment Options

For early-stage (T1–T2N0) glottic cancer, transoral CO₂ laser microsurgery (TLM) or radiotherapy provide equivalent local control. TLM shortens hospitalisation, offers fewer late side effects, and allows re-treatment. For advanced stage (T3–T4a) in eligible patients, concurrent chemoradiotherapy (CCRT) organ preservation strategy can be attempted, but the functional integrity of the larynx must be assessed. Total laryngectomy is performed when organ preservation is impossible, in salvage surgery, and in T4b cases. In selected cases, partial laryngeal surgery (supraglottic laryngectomy, supracricoid laryngectomy) may be applied.

Voice Rehabilitation and Follow-Up

Voice rehabilitation after total laryngectomy is central to quality of life. The tracheoesophageal voice prosthesis (TEP) consists of a small valve connecting the oesophagus to the trachea; it directs lung air to the oesophagus to produce sound. It is the most widely used method today. Oesophageal speech (belching speech) can be learned by naturally swallowing and releasing air. An electrolarynx produces sound through vibration when applied to the neck or mouth. Psychological support and multidisciplinary rehabilitation after laryngectomy are critical for long-term adjustment.

Frequently Asked Questions

What is the difference between laryngopharyngeal and laryngeal cancer?
Laryngeal cancer develops in the voice box (larynx) itself and most often begins in the glottic region (vocal cords). Laryngopharyngeal cancer affects both the larynx and the surrounding pharyngeal region. Glottic laryngeal cancer has a better prognosis because hoarseness presents early; supraglottic and hypopharyngeal cancers present later symptoms and are often diagnosed at a more advanced stage.
What are the risk factors for laryngeal cancer?
Smoking is the greatest risk factor, with risk in smokers 10–30 times higher than non-smokers. Alcohol has a synergistic effect with smoking. HPV (especially type 16) is emerging as an increasing risk factor, particularly for supraglottic and hypopharyngeal tumours. Chronic gastro-oesophageal reflux can cause laryngeal irritation. Occupational exposures (asbestos, paints) also carry risk.
How is early-stage laryngeal cancer treated?
For early-stage (T1–T2) glottic laryngeal cancer, two options exist: radiotherapy or transoral laser microsurgery (TLM). Both achieve >85–90% local control; comparisons regarding voice quality and organ preservation are ongoing. TLM has become standard at many centres. Treatment decisions should be made in a multidisciplinary tumour council.
Can the larynx be preserved in advanced laryngeal cancer?
Yes; studies such as RTOG 91-11 show that in eligible patients with advanced (T3–T4a) laryngeal cancer, laryngeal preservation is achievable in 60–70% of cases with chemoradiotherapy. However, even with organ "preservation", voice and swallowing function can be severely affected. Total laryngectomy is required for salvage surgery or cases where organ preservation is not achievable; post-surgical voice rehabilitation (electrolarynx, tracheoesophageal prosthesis) is possible.
Is it possible to speak after laryngeal cancer surgery?
After total laryngectomy, three voice rehabilitation options exist: speech with a tracheoesophageal voice prosthesis (provides the most natural voice quality), oesophageal speech, and an electrolarynx device. The tracheoesophageal prosthesis method is the preferred approach today; the vast majority of patients can speak intelligibly 1–3 months after surgery.
What are the 5-year survival rates for laryngeal cancer?
5-year survival for Stage I glottic laryngeal cancer is 90–95% — one of the best prognoses among major cancers. Stage II: 80–85%; Stage III: 60–70%; Stage IVA: approximately 40–50%. This is why early evaluation of hoarseness can be life-saving.

Have a specific question? Contact us for a personalised assessment.

Every patient's anatomy, expectations and clinical picture is different. Reach us on WhatsApp or via the contact form — Prof. Dr. Hasan Ahmet Özdoğan will get back with a personalised assessment.

Share this post

Was this article helpful?

👨‍⚕️ Ask the doctor (anonymous)

Don't share personal information. Questions are answered in batches by category; 48-72 hour turnaround by email. Not a medical diagnosis.

On similar topics

Related posts

References
Message on WhatsAppCall